Kamunting Street Capital Management, L.P. Ocular Therapeutix, Inc Transaction History

Kamunting Street Capital Management, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.01 - $5.22 $283,307 - $491,316	-94,122 Reduced 25.46%	275,506 $1.11 Million
Q1 2022 May 16, 2022	SELL	$4.83 - $7.35 $281,584 - $428,497	-58,299 Reduced 13.62%	369,628 $1.83 Million
Q4 2021 Feb 14, 2022	SELL	$6.16 - $12.07 $2.25 Million - $4.4 Million	-364,497 Reduced 46.0%	427,927 $2.98 Million
Q3 2021 Nov 15, 2021	BUY	$9.7 - $14.34 $1.63 Million - $2.41 Million	168,223 Added 26.95%	792,424 $7.92 Million
Q2 2021 Aug 16, 2021	BUY	$13.43 - $19.16 $2.52 Million - $3.6 Million	187,894 Added 43.06%	624,201 $8.85 Million

Q1 2021 May 17, 2021	BUY	$15.82 - $22.11 $5.8 Million - $8.11 Million	366,806 Added 527.77%	436,307 $7.16 Million
Q4 2020 Feb 16, 2021	SELL	$7.91 - $22.95 $190,520 - $552,773	-24,086 Reduced 25.74%	69,501 $1.44 Million
Q3 2020 Nov 16, 2020	BUY	$7.36 - $9.87 $688,800 - $923,703	93,587 New	93,587 $712,000

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Kamunting Street Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Kamunting Street Capital Management, L.P. with notifications on news.